“Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”. 2022. SKIN The Journal of Cutaneous Medicine 6 (2): 109-21. https://doi.org/10.25251/skin.6.2.4.